戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tinal model and an ex vivo absorption model (Ussing chambers).
2  overcome permeability defect (quantified in Ussing chambers).
3 s of differing age and mounted in a modified Ussing chamber.
4  human fetal eyes were mounted in a modified Ussing chamber.
5 it conjunctiva was evaluated in the modified Ussing chamber.
6 ical resistance in rat jejunum mounted in an Ussing chamber.
7 olayers; channel function was measured in an Ussing chamber.
8  cells, and their function was studied in an Ussing chamber.
9 BM/choroid (BM/Ch) was mounted in a modified Ussing chamber.
10 ears; range 39-84) was mounted in a modified Ussing chamber.
11 orded across Calu-3 monolayers mounted in an Ussing chamber.
12 choroid explants was evaluated in a modified Ussing chamber.
13 p technique and transepithelial secretion by Ussing chamber.
14 human neuroretina were mounted in a modified Ussing chamber.
15 e triphosphate (ATP) assay, or mounted in an Ussing chamber.
16 leum, jejunum, and colon was evaluated in an Ussing chamber.
17  difference in rat jejunal tissue mounted in Ussing chambers.
18             Tissues were mounted in modified Ussing chambers.
19  mice and increases short circuit current in Ussing chambers.
20 toskeletal damage, or enterotoxic effects in Ussing chambers.
21 rt-circuited preparations of distal colon in Ussing chambers.
22  to luminal nucleotide additions measured in Ussing chambers.
23 mal duodenal mucosa was examined in vitro in Ussing chambers.
24 (MTEs) were apically infected and assayed in Ussing chambers.
25 ng ion fluxes across epithelial membranes in Ussing chambers.
26 xin was evaluated in rabbit ileum mounted in Ussing chambers.
27  subjected to 1 h of ischemia was mounted in Ussing chambers.
28 in rat intestine and adenocarcinoma cells in Ussing chambers.
29 r function and electrogenic ion transport in Ussing chambers.
30 lar flux measurements on biopsies mounted in Ussing chambers.
31 essed as changes in short circuit current in Ussing chambers.
32 nd Il10(-/-) mice with or without colitis in Ussing chambers.
33 ected ileum on barrier function ex vivo with Ussing chambers.
34 Da)] in duodenal biopsy specimens mounted in Ussing chambers.
35 solateral potassium transport was studied in Ussing chambers.
36 trical conductance when assessed in modified Ussing chambers.
37 O(3)(-) secretion was measured by pH stat in Ussing chambers.
38 ts across intestinal segments as measured in Ussing chambers.
39 ained for immunohistochemistry or mounted in Ussing chambers.
40 -injured porcine ileal mucosa was mounted in Ussing chambers.
41 of small bowel from the mice were mounted in Ussing chambers.
42 ripped of seromuscular layers and mounted in Ussing chambers.
43 on, infected with Salmonella, and mounted in Ussing chambers.
44 hort circuit current ( triangle up I(sc)) in Ussing chambers.
45 d and ion transport changes were measured in Ussing chambers.
46 vated short circuit currents when mounted in Ussing chambers.
47 l side of ileal mucosal membranes mounted in Ussing chambers after 10(9) Escherichia coli C-25 had be
48                                              Ussing chamber analysis of jejunum revealed that Na+/H+
49 otential difference analyses and in vitro by Ussing chamber analysis.
50 lation have been investigated using both the Ussing chamber and a superfusion apparatus.
51 gically removed sclera clamped in a modified Ussing chamber and connected to a water column set at in
52                                           An Ussing chamber and contractility apparatus were used to
53 nasal epithelia cultures using experimental (Ussing Chamber and microelectrode) data reported in the
54              We also used electrophysiologic Ussing chamber and patch clamp experiments to analyze ac
55 rmeable support to confluence, mounted in an Ussing chamber and permeabilized apically with amphoteri
56 as used for in vitro functional studies with Ussing chamber and pH stat techniques.
57                                           By Ussing chamber and radiotracer flux studies, claudin-8 e
58 current from rat jejunal tissue mounted in a Ussing chamber and rounding of intestinal epithelial cel
59 mined using ciliary body sections mounted in Ussing chambers and a perfused eye preparation.
60              Rabbit intestine was mounted in Ussing chambers and exposed to increasing concentrations
61 om C57BL/6 (wild-type) and Cftr(-/-) mice in Ussing chambers and measured transcellular secretion of
62  paracellular permeability were monitored in Ussing chambers and micro-snapwells.
63 anges, we mounted bladder tissue in modified Ussing chambers and subjected the tissue to mechanical s
64 tion was assessed in vitro with 51Cr-EDTA in Ussing chambers and was expressed as the permeability co
65 fluence on a porous substrate, mounted in an Ussing chamber, and the apical plasma membrane permeabil
66 gnificance, NRC monolayers were mounted in a Ussing chamber, and the short-circuit current ( I sc ) w
67          Segments of jejunum were mounted in Ussing chambers, and short circuit current responses to
68                        Using patch clamp and Ussing chamber approaches, this study reveals that BK ch
69 allenge, we used a capillary to construct an Ussing chamber (area <1 mm(2)) to measure electrolyte tr
70  tested for their biological activity in the Ussing chamber assay and their ability to bind to the ta
71 easured by in situ potential differences and Ussing chamber assays and correction of CFTR in both air
72 n blot, and electrophysiological assessment (Ussing chamber) at 4, 8, and 14 hours.
73 d SC barrier function were investigated with Ussing chamber-based IS.
74                                           In Ussing chambers, basolaterally applied AVP reduced colon
75                                           In Ussing chambers, BFT had two effects.
76  in rabbit colonic mucosal sheets mounted in Ussing chambers by 91%.
77 etion across duodenal mucosa was measured in Ussing chambers by pH stat and (36)Cl flux methods using
78  (PGE(2)) receptors, EP1-4, were examined in Ussing-chambers by exposing biopsies to selective EP rec
79 at the existing theoretical treatment of the Ussing chamber consists of the super-imposition of two c
80 PP2A1, PP2A2) into the apical compartment of Ussing chambers containing Calu-3 monolayers.
81                                              Ussing chamber data indicated in vitro function consiste
82                                 Studies with Ussing chambers demonstrated reduced basal and/or adenos
83 00 mum) added into the apical compartment of Ussing chambers either prior or after GSNO either comple
84                          GBs were mounted in Ussing chambers, electrophysiologic parameters were reco
85 by nasal potential difference in mice and by Ussing chamber electrophysiology in vitro.
86 gamma-S stimulation of monolayers mounted in Ussing chambers evoked a rapid, but transient decrease i
87                                           In Ussing chamber experiments employing both human and mous
88                                              Ussing chamber experiments indicated a time-dependent de
89                                              Ussing chamber experiments indicated that serosal 1 micr
90                                              Ussing chamber experiments revealed electrogenic glucose
91 us inhibitors and activators was examined by Ussing chamber experiments.
92 ants were grown on filters and mounted in an Ussing chamber for electrophysiological studies.
93 rabbit conjunctiva was mounted in a modified Ussing chamber for measurement of short-circuit current
94 rabbit conjunctiva was mounted in a modified Ussing chamber for the measurement of short-circuit curr
95 f bovine and human fetal RPE were mounted in Ussing chambers for measurements of cytosolic calcium le
96 der an air-liquid interface, were mounted in Ussing chambers for the measurements of chloride short c
97                                          The Ussing chamber has been used for many years to measure b
98                                          The Ussing chamber method was used to study the electrophysi
99 de in the receptor chamber using an in vitro Ussing chamber model.
100                                           In Ussing chambered mucosa-submucosa preparations (includin
101 lial cells, bladder mucosa sheets mounted in Ussing chambers or isolated bladder strips in organ bath
102 ed tongue epithelia were mounted in modified Ussing chambers, permitting apical stimulation of taste
103              Colon tissues were isolated and Ussing chambers, quantitative polymerase chain reaction,
104 otes) were used to determined ENaC activity (Ussing chamber recordings), ASL height (confocal microsc
105 dies of primary nasal epithelial cultures in Ussing chambers revealed that inhibition of endogenous s
106 ing, and short-circuit currents (measured in Ussing chambers) revealed 2-fold higher stretch-activate
107 ort was electrophysiologically registered in Ussing-chamber set-ups, mRNA level of selected transport
108 ties of ouabain were evaluated in a modified Ussing chamber setup, using conjunctival tissues freshly
109                                           In Ussing chamber studies of chloride secretion, adenine nu
110                                              Ussing chamber studies of rat AT2 cells indicated that a
111 either anastomosed at 4 weeks or excised for Ussing chamber studies or histology, immunohistochemistr
112                                              Ussing chamber studies revealed that colons infected wit
113                                              Ussing chamber studies showed that cAMP-dependent and ch
114                                           In Ussing chamber studies, 5-HT-induced I(SC) and DMBS were
115                                          The Ussing chamber system can be utilised as a valuable tool
116                                          The Ussing chamber system methodology we describe provides s
117 rpose of this study is to investigate, in an Ussing chamber system, whether elemental vs. parenteral
118 normal ileal mucosal membranes tested in the Ussing chamber system.
119 al Cl(-) currents measured in vitro with the Ussing chamber technique, but not with those determined
120 from macaques infected with C. parvum by the Ussing chamber technique.
121 on consists of isotopic flux measurements in Ussing chambers, the standard apparatus for permeation s
122  misinterpreted as enhanced secretion in the Ussing chamber, this is a serious deficiency in the evid
123  vivo using canine bladder mucosa mounted in Ussing chambers to determine the inflammatory and repara
124 e and Clcn2(-/-) littermates were mounted in Ussing chambers to determine transepithelial bioelectric
125  Muscle-free colonic mucosae were mounted in Ussing chambers to measure mucosal permeability and secr
126          Segments of jejunum were mounted in Ussing chambers to measure mucosal permeability; chlorid
127         Porcine scleral tissue was placed in Ussing chambers to separate uveal and orbital compartmen
128                                           In Ussing chambers, trypsin and AP stimulated a short-circu
129  assessed by direct measurement of NO in the Ussing chamber using an ISO-NO meter) decreased I(sc) pa
130          TASK-3 activation was quantified by Ussing chamber voltage clamp analysis.
131             In rabbit ileum studied with the Ussing chamber-voltage clamp technique, EGF stimulation
132                                           An Ussing chamber was constructed and adapted to support bo
133  confluent epithelial monolayers measured in Ussing chambers was 9-fold larger in hTE compared with C
134 nsport across the bovine ciliary body in the Ussing chambers was greater in the aqueous humor-to-bloo
135 ge across the ileal membranes mounted in the Ussing chambers was significantly increased in the ileal
136                                  By means of Ussing chambers, we show that AVP reduced colonic anion
137 hed healthy women (controls) were mounted in Ussing chambers; we measured numbers of fluorescently la
138        Human mucosal preparations mounted in Ussing chambers were exposed to NT.
139 esistance in human colonic mucosa mounted in Ussing chambers were reversed by 60 and 68%, respectivel
140                                              Ussing chambers were used to measure transepithelial (22
141 fluent monolayers of these cells, mounted in Ussing chambers, were stimulated to secrete Cl(-) by app
142 d within the intact epithelium in a modified Ussing chamber, which allowed us to flow tastants across
143 primary airway epithelia were analyzed in an Ussing chamber with treatment of amiloride followed by C
144          Transport studies were performed in Ussing chambers with intact and RPE-denuded specimens of
145 ches: formation of asymmetric bilayers in an Ussing chamber, with only one of two leaflets containing

 
Page Top